168 related articles for article (PubMed ID: 2527597)
21. [Preclinical evaluation of aromatase inhibitors antitumor activity].
Auvray P; Bichat F; Genne P
Bull Cancer; 2000 Dec; 87 Spec No():7-22. PubMed ID: 11250604
[TBL] [Abstract][Full Text] [Related]
22. The control and biological importance of intratumoural aromatase in breast cancer.
Dowsett M; Lee K; Macaulay VM; Detre S; Rowlands M; Grimshaw R
J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):145-50. PubMed ID: 8603035
[TBL] [Abstract][Full Text] [Related]
23. Aromatase in breast cancer and the role of aminoglutethimide and other aromatase inhibitors.
Brodie AM; Santen RJ
Crit Rev Oncol Hematol; 1986; 5(4):361-96. PubMed ID: 3094971
[TBL] [Abstract][Full Text] [Related]
24. Theoretical considerations for the ideal aromatase inhibitor.
Dowsett M
Breast Cancer Res Treat; 1998; 49 Suppl 1():S39-44; discussion S73-7. PubMed ID: 9797016
[TBL] [Abstract][Full Text] [Related]
25. Fadrozole and letrozole in advanced breast cancer: clinical and biochemical effects.
Smith IE; Norton A
Breast Cancer Res Treat; 1998; 49 Suppl 1():S67-71; discussion S73-7. PubMed ID: 9797020
[No Abstract] [Full Text] [Related]
26. Nonsteroidal and steroidal aromatase inhibitors in breast cancer.
Hamilton A; Volm M
Oncology (Williston Park); 2001 Aug; 15(8):965-72; discussion 972, 977-9. PubMed ID: 11548977
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of the actions of aromatase inhibitors 4-hydroxyandrostenedione, fadrozole, and aminoglutethimide on aromatase in JEG-3 cell culture.
Yue W; Brodie AM
J Steroid Biochem Mol Biol; 1997; 63(4-6):317-28. PubMed ID: 9459198
[TBL] [Abstract][Full Text] [Related]
28. Aminoglutethimide--a new endocrine therapy in breast cancer. A cancer research review.
Harris AL
Exp Cell Biol; 1985; 53(1):1-8. PubMed ID: 3881300
[TBL] [Abstract][Full Text] [Related]
29. Emerging role of aromatase inhibitors in the treatment of breast cancer.
Harvey HA
Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):32-5. PubMed ID: 9556789
[TBL] [Abstract][Full Text] [Related]
30. Introduction to the conference, Aromatase: New Perspectives for Breast Cancer.
Santen RJ
Cancer Res; 1982 Aug; 42(8 Suppl):3268s. PubMed ID: 7083183
[No Abstract] [Full Text] [Related]
31. [Aromatase inhibitor].
Stein M
Med Monatsschr Pharm; 1993 Mar; 16(3):66-7. PubMed ID: 8464387
[No Abstract] [Full Text] [Related]
32. Clinical use of aromatase inhibitors in human breast carcinoma.
Santen RJ
J Steroid Biochem Mol Biol; 1991; 40(1-3):247-53. PubMed ID: 1835644
[TBL] [Abstract][Full Text] [Related]
33. A study of fadrozole, a new aromatase inhibitor, in postmenopausal women with advanced metastatic breast cancer.
Raats JI; Falkson G; Falkson HC
J Clin Oncol; 1992 Jan; 10(1):111-6. PubMed ID: 1530798
[TBL] [Abstract][Full Text] [Related]
34. Combined treatment with 4-hydroxyandrostenedione and aminoglutethimide: effects on aromatase inhibition and oestrogen suppression.
MacNeill FA; Jacobs S; Lønning PE; Powles TJ; Dowsett M
Br J Cancer; 1994 Jun; 69(6):1171-5. PubMed ID: 8198987
[TBL] [Abstract][Full Text] [Related]
35. Plasma estrone and estrone sulphate in breast cancer patients treated with the aromatase inhibitor CGS 16949A.
Klepp R; Lønning PE; Kvinnsland S
Acta Oncol; 1990; 29(4):469-71. PubMed ID: 2143909
[No Abstract] [Full Text] [Related]
36. [Aromatase inhibitors: pharmacological aspects].
de Crémoux P
Bull Cancer; 2000 Dec; 87 Spec No():23-29. PubMed ID: 11250605
[TBL] [Abstract][Full Text] [Related]
37. Fadrozole hydrochloride, a new nontoxic aromatase inhibitor for the treatment of patients with metastatic breast cancer.
Falkson G; Raats JI; Falkson HC
J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):161-5. PubMed ID: 1388048
[TBL] [Abstract][Full Text] [Related]
38. Aromatase inhibitors in breast cancer: current and evolving roles.
Hill J; Moore H
Cleve Clin J Med; 2002 Jul; 69(7):561-7. PubMed ID: 12109640
[TBL] [Abstract][Full Text] [Related]
39. Clinical development of aromatase inhibitors for the treatment of breast and prostate cancer.
Dowsett M
J Steroid Biochem Mol Biol; 1990 Dec; 37(6):1037-41. PubMed ID: 2149504
[TBL] [Abstract][Full Text] [Related]
40. Antitumor effect of a specific aromatase inhibitor, 1-methyl-androsta-1,4-diene-3,17-dione (atamestane), in female rats bearing DMBA-induced mammary tumors.
Nishino Y; Schneider MR; Michna H; el Etreby MF
J Steroid Biochem; 1989; 34(1-6):435-7. PubMed ID: 2533949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]